Mitchell K. How do Patient-Reported measures contribute to value in health care? vol. 2017: Institute of Healthcare Improvement; 2014.
FDA: Guidance for industry: Patient-Reported outcome measures: Use in medical product development to support labeling claims. 2009. https://www.fda.gov/media/77832/download. Accessed Feb 2018.
Calvert M, Kyte D, Mercieca-Bebber R, et al. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the spirit-pro extension. JAMA. 2018;319:483–94.
Article
PubMed
Google Scholar
Vodicka E, Kim K, Devine E, Gnanasakthy A, Scoggins J, Patrick D. Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007–2013). Contemp Clin Trials. 2015;43:1–9.
Article
CAS
PubMed
Google Scholar
Kyte D, Retzer A, Ahmed K, Keeley T, Armes J, Brown JM, Calman L, Gavin A, Glaser AW, Greenfield DM, et al. Systematic evaluation of Patient-Reported outcome protocol content and reporting in Cancer trials. J Natl Cancer Inst. 2019;111(11):1–9..
Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas. 2018;9:353–67.
Article
PubMed
PubMed Central
Google Scholar
Calvert M, Blazeby J, Revicki D, Moher D, Brundage M. Reporting quality of life in clinical trials: a CONSORT extension. Lancet. 2011;378:1684–5.
Article
PubMed
Google Scholar
REF 2014: Assessment framework and guidance on submissions [https://www.ref.ac.uk/2014/media/ref/content/pub/assessmentframeworkandguidanceonsubmissions/GOS%20including%20addendum.pdf]. Accessed Feb 2018.
Oxford Dictionaries - pathway [http://www.oxforddictionaries.com/definition/english/pathway]. Accessed July 2019.
Cruz Rivera S, Kyte DG, Aiyegbusi OL, Keeley TJ, Calvert MJ. Assessing the impact of healthcare research: a systematic review of methodological frameworks. PLoS Med. 2017;14:e1002370.
Article
PubMed
PubMed Central
Google Scholar
Royal Netherlands Academy of arts and sciences. The societal impact of applied health research - towards a quality assessment system [https://www.knaw.nl/en/news/publications/the-societal-impact-of-applied-health-research/@@download/pdf_file/20021098.pdf]. Accessed Feb 2018.
RAE 2008 - Guidance in submissions [http://www.rae.ac.uk/pubs/2005/03/rae0305.pdf]. Accessed Feb 2018.
Morton S. Progressing research impact assessment: A ‘contributions’ approach. Res Eval. 2015;24:405–19.
Article
Google Scholar
Primary Health Care Research Impact Project: Final Report Stage 1 [http://www.phcris.org.au/phplib/filedownload.php?file=/elib/lib/downloaded_files/publications/pdfs/phcris_pub_3338.pdf]. Accessed Feb 2018.
Brueton VC, Vale CL, Choodari-Oskooei B, Jinks R, Tierney JF. Measuring the impact of methodological research: a framework and methods to identify evidence of impact. Trials. 2014;15:464 461p.
Article
PubMed
PubMed Central
Google Scholar
Weiss AP. Measuring the impact of medical research: moving from outputs to outcomes. Am J Psychiatr. 2007;164:206–14.
Article
PubMed
Google Scholar
Lavis J, Ross S, McLeod C, Gildiner A. Measuring the impact of health research. J Health Serv Res Policy. 2003;8:165–70.
Article
PubMed
Google Scholar
Canavan J, Gillen A, Shaw A. Measuring research impact : developing practical and cost-effective approaches. Evid Policy. 2009;5:167–77.
Article
Google Scholar
Buykx P, Humphreys J, Wakerman J, Perkins D, Lyle D, McGrail M, Kinsman L. ‘Making evidence count’: a framework to monitor the impact of health services research. Aust J Rural Health. 2012;20:51–8.
Article
PubMed
Google Scholar
Spaapen J, van Drooge L. Introducing ‘productive interactions’ in social impact assessment. Res Eval. 2011;20:211–8.
Article
Google Scholar
Guinea J, Sela E, Gómez-Núñez AJ, Mangwende T, Ambali A, Ngum N, Jaramillo H, Gallego JM, Patiño A, Latorre C, et al. Impact oriented monitoring: a new methodology for monitoring and evaluation of international public health research projects. Res Eval. 2015;24:131–45.
Article
Google Scholar
Buxton M, Hanney S. How can payback from health services research be assessed? J Health Serv Res Policy. 1996;1:35–43.
Article
CAS
PubMed
Google Scholar
Meagher L, Lyall C, Nutley S. Flows of knowledge, expertise and influence: a method for assessing policy and practice impacts from social science research. Res Eval. 2008;17:163–73.
Article
Google Scholar
Graham KER, Chorzempa HL, Valentine PA, Magnan J. Evaluating health research impact: development and implementation of the Alberta innovates – health solutions impact framework. Res Eval. 2012;21:354–67.
Article
Google Scholar
Cohen G, Schroeder J, Newson R, King L, Rychetnik L, Milat AJ, Bauman AE, Redman S, Chapman S. Does health intervention research have real world policy and practice impacts: testing a new impact assessment tool. Health Res Policy Syst. 2014;13:3–3 1p.
Article
Google Scholar
Kuruvilla S, Mays N, Pleasant A, Walt G. Describing the impact of health research: a research impact framework. BMC Health Serv Res. 2006;6:134.
Article
PubMed
PubMed Central
Google Scholar
Kok MO, Schuit AJ. Contribution mapping: a method for mapping the contribution of research to enhance its impact. Health Res Policy Syst. 2012;10.
Landry R, Amara N, Lamari M. Climbing the ladder of research utilization - evidence from social science research. Sci Commun. 2001;22:396–422.
Article
Google Scholar
Canadian Institutes of Health Research. Developing a CIHR framework to measure the impact of health research [http://publications.gc.ca/collections/Collection/MR21-65-2005E.pdf]. Accessed Feb 2018.
Canadian Academy of Health Sciences. Making an impact - A preferred framework and indicators to measure returns on investment in health research [http://www.cahs-acss.ca/wp-content/uploads/2011/09/ROI_FullReport.pdf]. Accessed Feb 2018.
Sarli CC, Dubinsky EK, Holmes KL. Beyond citation analysis: a model for assessment of research impact. J Med Libr Assoc. 2010;98:17–23.
Article
PubMed
PubMed Central
Google Scholar
Donovan C. The Australian research quality framework: a live experiment in capturing the social, economic, environmental, and cultural returns of publicly funded research. N Dir Eval. 2008;118:47–60.
Article
Google Scholar
Jacob R, McGregor M. Assessing the impact of health technology assessment. Int J Technol Assess Health Care. 1997;13:68–80.
Article
CAS
PubMed
Google Scholar
Reed M. What makes a 4* research impact case study for REF2021? In: Fast Track Impact, vol. 2018; 2017.
Google Scholar
Penfield T, Baker MJ, Scoble R, Wykes MC. Assessment, evaluations, and definitions of research impact: a review. Res Eval. 2014;23:21–32.
Article
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Article
PubMed
PubMed Central
Google Scholar
iProspect. iProspect Search Engine User Behavior Study: iProspectcom, Inc; 2006.
Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88.
Article
PubMed
Google Scholar
Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D'Haese S, Zurlo A. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials -- does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol. 2003;21:3502–11.
Article
PubMed
Google Scholar
Bjordal K. Impact of quality of life measurement in daily clinical practice. Ann Oncol. 2004;15:iv279–82.
Article
PubMed
Google Scholar
Avery K, Blazeby JM. Quality of life assessment in surgical oncology trials. World J Surg. 2006;30:1163–72.
Article
PubMed
Google Scholar
Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer. 2008;44:1497–506.
Article
PubMed
Google Scholar
Gujral S, Avery KNL, Blazeby JM. Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials. Support Care Cancer. 2008;16:127–32.
Article
PubMed
Google Scholar
Parameswaran R, McNair A, Avery KN, Berrisford RG, Wajed SA, Sprangers MA, Blazeby JM. The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol. 2008;15:2372–9.
Article
CAS
PubMed
Google Scholar
Lemieux J, Goodwin PJ, Bordeleau LJ, Lauzier S, Theberge V. Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009). J Natl Cancer Inst. 2011;103:178–231.
Article
PubMed
Google Scholar
Calvert M, Brundage M, Jacobsen PB, Schunemann HJ, Efficace F. The CONSORT Patient-Reported outcome (PRO) extension: implications for clinical trials and practice. Health Qual Life Outcomes. 2013;11:184.
Article
PubMed
PubMed Central
Google Scholar
Jacobs M, Macefield RC, Blazeby JM, Korfage IJ, Henegouwen MIV, de Haes H, Smets EM, Sprangers MAG. Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Qual Life Res. 2013;22:1787–803.
Article
PubMed
Google Scholar
Dirven L, Taphoorn MJB, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P, Efficace F, Patient Reported O. The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review. Eur J Cancer. 2014;50:2432–48.
Article
PubMed
Google Scholar
Efficace F, Feuerstein M, Fayers P, Cafaro V, Eastham J, Pusic A, Blazeby J. Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making. Eur Urol. 2014;66:416–27.
Article
PubMed
Google Scholar
Efficace F, Jacobs M, Pusic A, Greimel E, Piciocchi A, Kieffer JM, Gilbert A, Fayers P, Blazeby J, Registry EQoLGPROMOTIO-P. Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making. Eur J Cancer. 2014;50:1925–41.
Article
PubMed
Google Scholar
Rees JR, Whale K, Fish D, Fayers P, Cafaro V, Pusic A, Blazeby JM, Efficace F. Patient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-making. J Cancer Res Clin Oncol. 2015;141:2181–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rouette J, Blazeby J, King M, Calvert M, Peng Y, Meyer RM, Ringash J, Walker M, Brundage MD. Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists' perspectives. Qual Life Res. 2015;24:1317–25.
Article
PubMed
Google Scholar
McNair AGK, Macefield RC, Blencowe NS, Brookes ST, Blazeby JM. ‘Trial exegesis’: methods for synthesizing clinical and Patient Reported outcome (PRO) data in trials to inform clinical practice. A systematic review. PLoS One. 2016;11:e0160998.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol. 2006;24:3178–86.
Article
PubMed
Google Scholar
Snyder C, Brundage M. Integrating patient-reported outcomes in healthcare policy, research and practice. Expert Rev Pharmacoecon Outcomes Res. 2010;10:351–3.
Article
PubMed
Google Scholar
Calvert M, Brundage M, Jacobsen PB, Schünemann HJ, Efficace F. The CONSORT Patient-Reported outcome (PRO) extension: implications for clinical trials and practice. Health Qual Life Outcomes. 2013;11:184.
Article
PubMed
PubMed Central
Google Scholar
Bottomley A, Efficace F, Thomas R, Vanvoorden V, Ahmedzai SH. Health-related quality of life in non–small-cell lung Cancer: methodologic issues in randomized controlled trials. J Clin Oncol. 2003;21:2982–92.
Article
PubMed
Google Scholar
Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials – a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer. 2008;44:1497–506.
Article
PubMed
Google Scholar
Ganz PA. Assessing the quality and value of quality-of-life measurement in breast Cancer clinical trials. J Natl Cancer Inst. 2011;103:196–9.
Article
PubMed
Google Scholar
Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality-of-life measurement in randomized clinical trials in breast Cancer—taking stock. J Natl Cancer Inst. 2003;95:263–81.
Article
PubMed
Google Scholar
Hao Y, Krohe M, Yaworsky A, Shields AL, Mazar I, Foley C, Globe D. Clinical trial Patient-reported outcomes data: going beyond the label in oncology. Clin Ther. 2016;38:811–20.
Article
PubMed
Google Scholar
Jacobs M, Macefield RC, Blazeby JM, Korfage IJ, van Berge Henegouwen MI, de Haes HCJM, Smets EM, Sprangers MAG. Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Qual Life Res. 2013;22:1787–803.
Article
PubMed
Google Scholar
McNair AG, Blazeby JM. Health-related quality-of-life assessment in GI cancer randomized trials: improving the impact on clinical practice. Expert Rev Pharmacoecon Outcomes Res. 2009;9:559–67.
Article
PubMed
Google Scholar
Mercieca-Bebber RL, Perreca A, King M, Macann A, Whale K, Soldati S, Jacobs M, Efficace F. Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: a systematic review of completeness of reporting and impact on interpretation. Eur J Cancer. 2016;56:144–61.
Article
PubMed
Google Scholar
Mott FE. Patient Reported outcomes (PROs) as part of value-based care can shape therapy guidelines: impact on emerging targeted agents and immunotherapy protocols in resource-limited regions. Oncol Ther. 2017;5:69–74.
Article
PubMed
Google Scholar
Basch E, Geoghegan C, Coons S, et al. Patient-reported outcomes in cancer drug development and us regulatory review: perspectives from industry, the food and drug administration, and the patient. JAMA Oncol. 2015;1:375–9.
Article
PubMed
Google Scholar
Au H-J, Ringash J, Brundage M, Palmer M, Richardson H, Meyer RM. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. Expert Rev Pharmacoecon Outcomes Res. 2010;10:119–28.
Article
PubMed
Google Scholar
Glasziou PP, Mar CD, Salisbury J. Evidence-Based Practice Workbook: Wiley; 2009.
Kristensen N, Nymann C, Konradsen H. Implementing research results in clinical practice- the experiences of healthcare professionals. BMC Health Serv Res. 2016;16:1–10.
Google Scholar
Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, Rothman M. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res. 2000;9:887–900.
Article
CAS
PubMed
Google Scholar
Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health. 2007;10(Suppl 2):S125–37.
Article
PubMed
Google Scholar
Doward LC, Gnanasakthy A, Baker MG. Patient reported outcomes: looking beyond the label claim. Health Qual Life Outcomes. 2010;8:89.
Article
PubMed
PubMed Central
Google Scholar
DeMuro C, Clark M, Mordin M, Fehnel S, Copley-Merriman C, Gnanasakthy A. Reasons for rejection of Patient-Reported outcome label claims: a compilation based on a review of Patient-Reported outcome Use among new molecular entities and biologic license applications, 2006–2010. Value Health. 2012;15:443–8.
Article
PubMed
Google Scholar
Coon CD. The Use of Patient-reported outcomes in demonstrating safety and efficacy in oncology. Clin Ther. 2016;38:756–8.
Article
PubMed
Google Scholar
Anker SD, Agewall S, Borggrefe M, Calvert M, Jaime Caro J, Cowie MR, Ford I, Paty JA, Riley JP, Swedberg K, et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J. 2014;35:2001–9.
Article
PubMed
Google Scholar
Gnanasakthy A, DeMuro C, Clark M, Haydysch E, Ma E, Bonthapally V. Patient-Reported outcomes labeling for products approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014). J Clin Oncol. 2016;34:1928–34.
Article
CAS
PubMed
Google Scholar
Arpinelli F, Bamfi F. The FDA guidance for industry on PROs: the point of view of a pharmaceutical company. Health Qual Life Outcomes. 2006;4:85.
Article
PubMed
PubMed Central
Google Scholar
Zagadailov E, Fine M, Shields A. Patient-Reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers. Am Health Drug Benefits. 2013;6:264–74.
PubMed
PubMed Central
Google Scholar
Sztankay M, Giesinger JM, Zabernigg A, Krempler E, Pall G, Hilbe W, Burghuber O, Hochmair M, Rumpold G, Doering S, Holzner B. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting. BMC Cancer. 2017;17:565.
Article
PubMed
PubMed Central
Google Scholar
Nixon AWD, Muehlhausen W. Patient reported outcomes to supoort drug development decision making. Farmeconomia Health Econ Ther Pathways. 2015;16:35–7.
Article
Google Scholar
Rees J, Hurt CN, Gollins S, Mukherjee S, Maughan T, Falk SJ, Staffurth J, Ray R, Bashir N, Geh JI, et al. Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. Br J Cancer. 2015;113:603–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brundage M, Bass B, Davidson J, Queenan J, Bezjak A, Ringash J, Wilkinson A, Feldman-Stewart D. Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers. Qual Life Res. 2011;20:653–64.
Article
PubMed
Google Scholar
Dirven L, Taphoorn MJB, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P, Efficace F. The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review. Eur J Cancer. 2014;50:2432–48.
Article
PubMed
Google Scholar
Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measure in routine clinical practice: lack of impact or lack of theory? Soc Sci Med. 2005;60:833–43.
Article
PubMed
Google Scholar
Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, Revicki DA, Symonds T, Parada A, Alonso J. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res. 2008;17:179–93.
Article
CAS
PubMed
Google Scholar
Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, Clarke M, Gargon E, Gorst S, Harman N, et al. The COMET handbook: version 1.0. Trials. 2017;18:280.
Article
PubMed
PubMed Central
Google Scholar
Calvert M, Kyte D, Price G, Valderas JM, Hjollund NH. Maximising the impact of patient reported outcome assessment for patients and society. BMJ. 2019;364:k5267.
Article
PubMed
Google Scholar
Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, et al. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Lancet Oncol. 2016;17:e510–4.
Article
PubMed
Google Scholar
Snyder CF, Smith KC, Bantug ET, Tolbert EE, Blackford AL, Brundage MD, the PRODPSAB. What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability. Cancer. 2017;123:1848–59.
Article
PubMed
Google Scholar
"PROTEUS" Patient-Reported outcomes tools: engaging users & stakeholders [https://www.pcori.org/research-results/2018/proteus-patient-reported-outcomes-tools-engaging-users-stakeholders]. Accessed June 2019.
Use CfMPfH. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. London: European Medicines Agency; 2005.
Google Scholar
REF 2014 impact case studies. 'Heart failure: improving the quality of life and survival of heart failure patients through cardiac resynchronisation therapy' [https://impact.ref.ac.uk/casestudies/CaseStudy.aspx?Id=38798]. Accessed Nov 2017.
REF 2014 impact case studies, 'Improving well-being and outcome for patients with heart failure using cardiac resynchronisation therapy (CRT)' [https://impact.ref.ac.uk/casestudies/CaseStudy.aspx?Id=36388]. Accessed Nov 2017.
University of Oxford - PROM Group Construct & Instrument Type Filters [https://cosmin.nl/wp-content/uploads/prom-search-filter-oxford-2010.pdf]. Accessed April 2017